US Representative

Gus Bilirakis 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 12)

Legislative Session

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4275

Introduced
6/22/23  
Refer
6/22/23  
Consensual Donation and Research Integrity Act of 2023

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB431

Introduced
1/20/23  
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4315

Introduced
6/23/23  
Refer
6/23/23  
Medicare Orthotics and Prosthetics Patient-Centered Care Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4323

Introduced
6/23/23  
Refer
6/23/23  
Protecting Whales, Human Safety and the Economy Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4335

Introduced
6/23/23  
VA Loan Informed Disclosure Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB435

Introduced
1/20/23  
Protecting Life on College Campus Act of 2023 This bill prohibits the award of federal funds to an institution of higher education (IHE) that hosts or is affiliated with a school-based service site that provides abortion drugs or abortions to its students or to employees of the IHE or the site. An IHE that hosts or is affiliated with a site must, in order to remain eligible for federal funds, annually certify that the site does not provide abortion drugs or abortions to students or employees.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4438

Introduced
6/30/23  
Refer
6/30/23  
John W. Walsh Alpha-1 Home Infusion Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4468

Introduced
7/6/23  
Refer
7/6/23  
Refer
7/7/23  
Report Pass
7/27/23  
Choice in Automobile Retail Sales Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4489

Introduced
7/6/23  
Refer
7/6/23  
To amend the 21st Century Cures Act to clarify that grants for State and Tribal response to opioid use disorders may, at the discretion of the Secretary of Health and Human Services, also be used to address associated health conditions, and for other purposes.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4531

Introduced
7/11/23  
Refer
7/11/23  
Report Pass
7/19/23  
Report Pass
9/28/23  
Support for Patients and Communities Reauthorization Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4563

Introduced
7/11/23  
Refer
7/11/23  
Refer
7/11/23  
ACE Act End Zuckerbucks Act of 2023 Solving an Overlooked Loophole in Votes for Executives (SOLVE) Act Promoting Free and Fair Elections Act Don't Weaponize the IRS Act American Confidence in Elections Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4663

Introduced
7/14/23  
Refer
7/14/23  
Federal Mechanical Insulation Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB467

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Report Pass
3/24/23  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4686

Introduced
7/17/23  
Flood Insurance Affordability Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4721

Introduced
7/18/23  
Main Street Tax Certainty Act